WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 74.00
0.00 (0.00%)
At close: Dec 5, 2025
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.37 billion as of December 5, 2025. Its market cap has increased by 17.31% in one year.
Market Cap
3.37B
Enterprise Value
3.93B
Revenue
1.06B
Ranking
n/a
PE Ratio
17.10
Stock Price
74.00
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.37B, a decrease of -1.89%. That is a compound annual growth rate of -0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.37B | 3.77% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |